Conexeu Sciences Inc.(CNXU)

Biotechnology · Reno, NV

$3.33+0.21 (+6.73%)

Delayed quote: Oct 6, 2026, 9:34 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T13:36:07.312Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:07.312Z.

Quote observation: 2026-10-06T13:34:58.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 89,105,232
Total debt: N/A
Cash: N/A
TTM operating EBITDA: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNXU EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

CNXU Competitors' EV/EBITDA Ratio

CNXU

Conexeu Sciences Inc.

Current

Market Cap

$89.11M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Equillium, Inc.

vs CNXU

Market Cap

$89.15M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDF

Cardiff Oncology, Inc.

vs CNXU

Market Cap

$89.36M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCC

ImmuCell Corporation

vs CNXU

Market Cap

$88.52M

EV/EBITDA Ratio

14.74x

TTM Avg

15.77x

3Y Avg

20.95x

5Y Avg

32.73x

CCLD

CareCloud, Inc.

vs CNXU

Market Cap

$88.17M

EV/EBITDA Ratio

4.68x

TTM Avg

4.46x

3Y Avg

3.36x

5Y Avg

3.41x

ACRV

Acrivon Therapeutics, Inc. Common Stock

vs CNXU

Market Cap

$87.74M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ECOR

electroCore, Inc.

vs CNXU

Market Cap

$91.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMEA

Biomea Fusion, Inc.

vs CNXU

Market Cap

$92.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATRA

Atara Biotherapeutics, Inc.

vs CNXU

Market Cap

$84.61M

EV/EBITDA Ratio

N/A

TTM Avg

8.06x

3Y Avg

8.06x

5Y Avg

8.06x

HUMA

Humacyte, Inc.

vs CNXU

Market Cap

$84.55M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Conexeu Sciences Inc. (CNXU)	$89.11M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$89.15M	N/A	N/A	N/A	N/A
Cardiff Oncology, Inc. (CRDF)vs ›	$89.36M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$88.52M	14.74x	15.77x	20.95x	32.73x
CareCloud, Inc. (CCLD)vs ›	$88.17M	4.68x	4.46x	3.36x	3.41x
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$87.74M	N/A	N/A	N/A	N/A
electroCore, Inc. (ECOR)vs ›	$91.51M	N/A	N/A	N/A	N/A
Biomea Fusion, Inc. (BMEA)vs ›	$92.54M	N/A	N/A	N/A	N/A
Atara Biotherapeutics, Inc. (ATRA)vs ›	$84.61M	N/A	8.06x	8.06x	8.06x
Humacyte, Inc. (HUMA)vs ›	$84.55M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics